Inventor · disambiguated record
Oliver L. Saunders
Also filed as: SAUNDERS OLIVER · SAUNDERS OLIVER L
27 granted patents·9 pending applications·1,851 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
36 records- 0198US10988498B2Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogsGILEAD SCIENCES INC·Filed 2018·Granted Apr 27, 2021·28 cites·1 claims
- 0298US8853171B21′-substituted carba-nucleoside analogs for antiviral treatmentGILEAD SCIENCES INC·Filed 2012·Granted Oct 7, 2014·75 cites·18 claims
- 0398US8318682B21′substituted carba-nucleoside analogs for antiviral treatmentBUTLER THOMAS·Filed 2011·Granted Nov 27, 2012·110 cites·24 claims
- 0498US8008264B21′-substituted carba-nucleoside analogs for antiviral treatmentGILEAD SCIENCES INC·Filed 2009·Granted Aug 30, 2011·168 cites·24 claims
- 0598US7507420B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2005·Granted Mar 24, 2009·148 cites·32 claims
- 0698US7498302B2Disulfide prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2005·Granted Mar 3, 2009·123 cites·32 claims
- 0798US7129261B2Cytotoxic agentsMEDAREX INC·Filed 2002·Granted Oct 31, 2006·282 cites·24 claims
- 0898US7087600B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2002·Granted Aug 8, 2006·259 cites·32 claims
- 0998US6989452B2Disulfide prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2002·Granted Jan 24, 2006·284 cites·21 claims
- 1097USRE46762E1′-substituted carba-nucleoside analogs for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Granted Mar 27, 2018·28 cites·33 claims
- 1197US8034959B2Methods of treating cancer with an antibody-drug conjugateMEDAREX INC·Filed 2009·Granted Oct 11, 2011·37 cites·19 claims
- 1296US7977465B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2009·Granted Jul 12, 2011·14 cites·21 claims
- 1396US7842672B2Phosphonate inhibitors of HCVGILEAD SCIENCES INC·Filed 2007·Granted Nov 30, 2010·103 cites·107 claims
- 1495US10023600B2Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogsBUTLER THOMAS·Filed 2010·Granted Jul 17, 2018·37 cites·2 claims
- 1594US8809330B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Aug 19, 2014·18 cites·10 claims
- 1694US8486938B2Pyrazolo[1,5-a]pyrimidines for antiviral treatmentBABAOGLU KERIM·Filed 2011·Granted Jul 16, 2013·25 cites·3 claims
- 1794US8324179B2Nucleoside analogs for antiviral treatmentCHEN JAMES M·Filed 2008·Granted Dec 4, 2012·72 cites·22 claims
- 1892US9238039B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Jan 19, 2016·13 cites·38 claims
- 1984US9814739B22′-ethynyl nucleoside derivatives for treatment of viral infectionsNOVARTIS AG·Filed 2016·Granted Nov 14, 2017·2 cites·10 claims
- 2083US6576630B1Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2000·Granted Jun 10, 2003·21 cites·16 claims
- 2177US2025145654A1Compounds and methods for treating diseaseROME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2275US10428105B2Alkynyl nucleoside analogs as inhibitors of human rhinovirusNOVARTIS AG·Filed 2018·Granted Oct 1, 2019·1 cites·16 claims
- 2375US9556216B22′-Ethynyl nucleoside derivatives for treatment of viral infectionsANANDAN SAMPATH-KUMAR·Filed 2013·Granted Jan 31, 2017·2 cites·15 claims
- 2474US12187758B2Compounds and methods for treating diseaseROME THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·26 claims
- 2572US9988416B2Alkynyl nucleoside analogs as inhibitors of human rhinovirusNOVARTIS AG·Filed 2017·Granted Jun 5, 2018·1 cites·15 claims
- 2670US2021403497A1Processes and intermediates for the preparation of 1`-substituted carba-nucleoside analogsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2769US2023295212A1Compounds and methods for treating diseaseROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2867US9957275B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted May 1, 2018·0 cites·17 claims
- 2966US2018298011A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3062US2017190708A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3160US11779590B2AMP-activated protein kinase activating compounds and uses thereofSKYLARK BIOSCIENCE LLC·Filed 2021·Granted Oct 10, 2023·0 cites·10 claims
- 3259US2016130275A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3355US2025268925A1Methods of treating medical conditions and inhibiting line1 reverse transcriptase using a substituted adeninyl-propyloxy phosphonic acid or related compoundROME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3454US2024366649A14-ethynyl-3-hydroxy-tetrahydrofuranyl-adenine phosphoramidates and related compounds and their use in treating medical conditionsROME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3547US2003232864A1Novel Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 3643US11834469B2AMP-activated protein kinase activating compounds and uses thereofSKYLARK BIOSCIENCE LLC·Filed 2019·Granted Dec 5, 2023·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Oliver L. Saunders files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →